How is Ado-Trastuzumab Emtansine (Intravenous Route) dosed?
The dosage of Ado-Trastuzumab Emtansine (Intravenous Route) is determined by a healthcare professional based on the individual's medical condition, body weight, and response to treatment. The recommended dose for metastatic breast cancer is 3.6 mg/kg given as an intravenous infusion over 90 minutes every 3 weeks. For early breast cancer, the dose is the same, but the treatment is given every 3 weeks for a total of 1 year, followed by a 1-year treatment-free period. It is essential to consult with a healthcare professional for personalized dosing instructions.
What is the dosage form of Ado-Trastuzumab Emtansine (Intravenous Route)?
The dosage form of Ado-Trastuzumab Emtansine (Intravenous Route) is Powder for Solution.
What medications are contraindication with Ado-Trastuzumab Emtansine (Intravenous Route)?
Ado-Trastuzumab Emtansine may interact with other medications. It is essential to inform your doctor about all the medications you are currently taking, including prescription, over-the-counter medicines, and any herbal or dietary supplements. Some medications that may interact with Ado-Trastuzumab Emtansine include trastuzumab and taxane medicines, medications that may cause heart problems, medications that may cause infusion reactions, and certain antibiotics. Consult your doctor about any medications you are taking to determine if they may interact with Ado-Trastuzumab Emtansine.
How is Ado-Trastuzumab Emtansine (Intravenous Route) administered?
Ado-Trastuzumab Emtansine (Intravenous Route) is administered by a healthcare professional as an intravenous injection in a hospital or medical setting. The injection is typically given slowly over a period of 30-120 minutes. The dosage and frequency of administration depend on the individual patient's condition and medical history.
What are common precautions when taking Ado-Trastuzumab Emtansine (Intravenous Route)?
Common precautions when taking Ado-Trastuzumab Emtansine (Intravenous Route) include monitoring for heart failure, informing your doctor about any lung problems, being aware of infusion reactions, ensuring the medication is given under the supervision of a doctor, and informing your doctor about any allergies or unusual reactions to this medication or other medicines.